Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innoviva (INVA) EPS (Basic) (2016 - 2026)

Innoviva filings provide 16 years of EPS (Basic) readings, the most recent being $1.3 for Q3 2025.

  • On a quarterly basis, EPS (Basic) rose 6400.0% to $1.3 in Q3 2025 year-over-year; TTM through Dec 2025 was $1.57, a 1430.32% increase, with the full-year FY2025 number at $4.02, up 986.49% from a year prior.
  • EPS (Basic) hit $1.3 in Q3 2025 for Innoviva, up from $1.01 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $3.81 in Q3 2022 to a low of -$0.74 in Q1 2025.
  • Median EPS (Basic) over the past 5 years was $0.23 (2022), compared with a mean of $0.52.
  • Biggest five-year swings in EPS (Basic): plummeted 2850.0% in 2024 and later soared 6400.0% in 2025.
  • Innoviva's EPS (Basic) stood at -$0.07 in 2021, then plummeted by 101.22% to -$0.15 in 2022, then surged by 32.21% to -$0.1 in 2023, then crashed by 67.14% to -$0.17 in 2024, then skyrocketed by 873.73% to $1.3 in 2025.
  • The last three reported values for EPS (Basic) were $1.3 (Q3 2025), $1.01 (Q2 2025), and -$0.74 (Q1 2025) per Business Quant data.